Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02419573 · ClinicalTrials.gov registry record · NA

Pragmatic Airway Resuscitation Trial

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
3,004
Enrollment target

NCT02419573: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT02419573 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 3,004 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02419573, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
3,004 participants
Enrollment target

Study Summary

The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies.

Primary Outcome

Number of patient alive at 72 hours after episode.

Interventions

  • DEVICE Endotracheal Intubation
  • DEVICE Laryngeal Tube (King)

Trial Details

FieldValue
Enrollment Target 3,004 participants
Start Date 2015-12-01
Est. Completion 2017-12-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02419573 record still lists

NCT02419573 is an interventional study that assigns participants to a tested intervention. Its 3,004 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).

The record links to 0 conditions, and to 2 interventions - of which Endotracheal Intubation is the first listed.

NCT02419573 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02419573 about?

NCT02419573 is a clinical study titled "Pragmatic Airway Resuscitation Trial". The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies.

What is the current status of trial NCT02419573?

This trial is currently completed. It is a NA study. The enrollment target is 3,004 participants. The study started on 2015-12-01. Estimated completion is 2017-12-01.

What interventions are being tested in trial NCT02419573?

The interventions under investigation include: Endotracheal Intubation (DEVICE), Laryngeal Tube (King) (DEVICE).

Who is sponsoring clinical trial NCT02419573?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02419573's enrollment target sits among peer trials

3,004 40th of 2000 higher than 1,961 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02419573, the US trial registry maintained by the National Library of Medicine. NCT02419573 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.